Mode
Text Size
Log in / Sign up
N/A N=94 Randomized Screening

Audio and Video Brochures for Increasing Colorectal Cancer Screening Among Adults Living in Appalachia

Colorectal Carcinoma

Enrolled (actual)
94
Serious AEs
0.0%
Results posted
Dec 2023
Primary outcome: Primary: Number of Participants to Return Fecal Immunochemical Test (FIT) — 3; 4; 9 Participants

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Best Practice (Other); Fecal Immunochemical Test (Other); Health Education (Behavioral); Scheduled Notification (Other); Survey Administration (Other)
Age
Adult · 50+ yrs
Sex
All
Sponsor
Ohio State University Comprehensive Cancer Center
Primary completion
Feb 2022

Outcome Measures

OutcomeResultp-value
PRIMARY
Number of Participants to Return Fecal Immunochemical Test (FIT)
3; 4; 9

Summary

This clinical trial compares audio brochures and video brochures to usual care for increasing colorectal cancer (CRC) screening among adults living in Appalachia. Adults living in rural Appalachia experience increased rates of CRC, possibly due to the unique barriers to screening this population faces, such as lower socioeconomic status, limited health literacy, and less access to healthcare. The fecal immunochemical test (FIT) is a common CRC screening technique which allows individuals to complete the test at home and mail the kit back. A limitation of the current process for FIT screening outreach is that the instruction materials are heavy in text and not appropriate for individuals with limited health literacy. The audio and video brochures used in this clinical trial are instruction materials that have been specially designed to be appropriate for individuals of all health literacy levels. Providing these audio and video brochures with the FIT kits may increase CRC screening among adults living in Appalachia, compared to usual care.

Eligibility Criteria

Inclusion Criteria

  • Mid-life men and women (50-64 years old)
  • Live in Appalachia
  • Had a medical visit in the past two years
  • Are at average-risk for CRC (no history of CRC, polyps, inflammatory bowel disease, family history of CRC or hereditary CRC syndromes)
  • Are not within CRC screening guidelines (no fecal occult blood test/FIT in the past year; flexible sigmoidoscopy in past five years; colonoscopy in past ten years)
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT05810714). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search